Abstract
The incidence of UTUC in congenital pelvic kidneys is not statistically different from the kidneys located in the true retroperitoneum with very few reported cases. The incidence of UTUC in transplanted kidneys depends on the pre-existing risks of the donor and those acquired by the recipient. The majority of these cases are reported from the Balkan region and Southeast Asia due to consumption of aristolochic acid. We will review the current available literature data in this chapter.
This is a preview of subscription content, log in via an institution.
References
Abeshouse BS, Bhisitkul I. Crossed renal ectopia with and without fusion. Urol Int. 1959;9:63–91.
Cowan NG, et al. Renal autotransplantation: 27-year experience at 2 institutions. J Urol. 2015;194(5):1357–61.
Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades (0022–5347 (Print)).
Wein AJ, et al. Campbell-Walsh urology. Elsevier Health Sciences; 2015.
Kauffman HM, et al. Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int. 2006;19(8):607–20.
Chuang FR, et al. Increasing transplant cancer patient survival by conversion of immunosuppressive agents (0041–1345 (Print)).
Zhang A, et al. A retrospective review of patients with urothelial cancer in 3370 recipients after renal transplantation: a single-center experience. World J Urol. 2015;33(5):713–7.
Lai MK, Tai HC, Wang SM. Urothelial carcinoma in renal transplant recipients. In: Trzcinska M, editor. Kidney transplantation—new perspectives. InTech; 2011.
Kao Y-L, et al. Transitional cell carcinoma in renal transplant recipients. World J Surg. 2003;27(8):912–6.
Li XB, et al. Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol. 2008;15(1):53–7.
Engels EA, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306(17):1891–901.
Hevia V, et al. Transitional cell carcinoma of the kidney graft: an extremely uncommon presentation of tumor in renal transplant recipients. Case Rep Transplant. 2013;2013:196528.
Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet. 2000;355(9218):1886–7.
Stewart JH, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol. 2003;14(1):197–207.
Prabharasuth D, et al. Management of bladder cancer after renal transplantation. Urology. 2013;81(4):813–9.
Master VA, et al. Treatment and outcome of invasive bladder cancer in patients after renal transplantation. J Urol. 2004;171(3):1085–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Yau, R., Eshghi, M. (2018). Urothelial Carcinoma in Transplanted, Pelvic, and End Stage Kidneys. In: Eshghi, M. (eds) Urothelial Malignancies of the Upper Urinary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-51263-1_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-51263-1_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-51261-7
Online ISBN: 978-3-319-51263-1
eBook Packages: MedicineMedicine (R0)